1.
|
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAM307, NCT00046683
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CAM314, NCT00086580
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CLL-2007-FMP, RECF0496, INCA-RECF0496, EudraCT-2007-000327-18, NCT00564512
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: CALGB-10102, NCT00061945
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 0 to 70
Sponsor: Other
Protocol IDs: H8714, DIMSUM, NCT00048412
|
|
6.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: NCI
Protocol IDs: CALGB-100102, NCT00085449
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GCLLSG-CLL3X, EU-20554, MEDAC-FLUD.10/CLL, NCT00281983
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DUMC-1340-99-7, NCI-G99-1617, NCT00004143
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-19901, NCT00004857, CALGB-19901
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: ECOG-8998, E8998, NCT00006390
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor: NCI
Protocol IDs: MSKCC-01092, NCI-G01-2028, NCT00027560
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Under 75
Sponsor: NCI
Protocol IDs: FHCRC-1591.00, 5275, NCI-H02-0089, NCT00040846
|
|
13.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NU-99H8, NU-99H08, MILLENNIUM-NU-99H8, ILEX-NU-99H8, NCT00057967
|
|
14.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-03-C-0194, NCI-4553, 4553, NCT00064155
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Under 70
Sponsor: Other
Protocol IDs: BCM-H-10857, NCT00069992
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: BCM-H-8447, NCT00073879
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: UCLA-0309058, NCT00081068
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BRLX-FLUCAM106, BRLX-STA1-03-058, OHSU-HEM-03050-P, DMS-F0334, NCT00086775
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: Other
Protocol IDs: ID02-368, NCT00071396
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 30 and under at diagnosis
Sponsor: NCI
Protocol IDs: COG-ADVL0222, ADVL0222, NCI-05-C-0248, NCT00089349
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CALGB-10101, NCT00098670
|
|
22.
|
Phase: Phase II
Type: Supportive care
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CASE-CWRU-1Z04, CWRU-060419, NCT00109993, CASE-1Z04
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2004-0742, NCT00129753
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-0404, NCT00143065
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E1904, E1904, NCT00262925
|
